Minerva Neurosciences, Inc. (NERV) Files Annual Report with SEC
Minerva Neurosciences, Inc. (NASDAQ:NERV) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 11, 2026. The Healthcare company reported annual…
Read more
